The Efficacy of Transversus Abdominis Plane Block After Groin Hernia Repair
2 other identifiers
interventional
90
1 country
1
Brief Summary
The purpose of this study is to determine whether Transversus abdominis plane block is superior to placebo or superior to local infiltration in analgesic efficacy after groin hernia repair.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Jun 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 19, 2010
CompletedFirst Posted
Study publicly available on registry
January 20, 2010
CompletedStudy Start
First participant enrolled
June 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2011
CompletedNovember 18, 2011
November 1, 2011
1.4 years
January 19, 2010
November 17, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain scores by coughing between TAP block group and placebo group
Area under the curve (AUC)-pain during cough based on measurements at 0,2,4,6,8,19,24 hours postoperative
0,2,4,6,8,19 and 24 hours postoperative
Secondary Outcomes (5)
Pain scores by coughing between placebo and local infiltration and between TAP block and local infiltration.
0,2,4,6,8,19 and 24 hours postoperative
Total opioid consumption
0-24 hours postoperative
Postoperative nausea and vomiting
0,2,4,6,8,19,24 hours postoperative
Sedation
0,2,4,6,8,19,24 hours postoperative
Pain scores at rest between TAP block versus placebo and TAP block versus infiltration and infiltration versus placebo
0,2,4,6,8,19,24 hours postoperative
Study Arms (3)
Placebo
PLACEBO COMPARATORTAP block with 25 ml of saline Ilioinguinal block with 10 ml of saline and local infiltration with 40 ml of saline.
Local infiltration
ACTIVE COMPARATORIlioinguinal block with 10 ml of ropivacaine 0,375% Local infiltration with 40 ml of ropivacaine 0,375% Tap block with 25 ml of saline
Transversus abdominis plane block
EXPERIMENTAL25 ml of Ropivacaine 0,75%, Ilioinguinal block with 10 ml saline and local infiltration with 40 ml of saline.
Interventions
UL-guided TAP block with 25 ml of ropivacaine 0,75% unilateral, single dose, ilioinguinal block with 10 ml of saline and local infiltration with 40 ml of saline
UL-guided Tap block with 25 ml of saline single dose Ilioinguinal block with 10 ml of saline and local infiltration with saline 40 ml single dose
Ilioinguinal block with 10 ml of ropivacaine 0,375% single dose, local infiltration with 40 ml of ropivacaine 0,375% single dose, UL-guided Tap block with 25 ml of saline single dose
Eligibility Criteria
You may qualify if:
- years old
- groin hernia repair
- written consent
- ASA 1-3
- BMI 18-35
You may not qualify if:
- unable to communicate in Danish
- relevant drug allergy
- pain medication in the last 24 hours
- pregnancy
- alcohol or/and drug abuse
- daily opioid intake
- infection at injection site
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anaesthesiology, Glostrup university hospital
Glostrup Municipality, 2600, Denmark
Related Publications (1)
Petersen PL, Mathiesen O, Stjernholm P, Kristiansen VB, Torup H, Hansen EG, Mitchell AU, Moeller A, Rosenberg J, Dahl JB. The effect of transversus abdominis plane block or local anaesthetic infiltration in inguinal hernia repair: a randomised clinical trial. Eur J Anaesthesiol. 2013 Jul;30(7):415-21. doi: 10.1097/EJA.0b013e32835fc86f.
PMID: 23549122DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pernille L Petersen, MD
Glostrup University Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
January 19, 2010
First Posted
January 20, 2010
Study Start
June 1, 2010
Primary Completion
November 1, 2011
Study Completion
November 1, 2011
Last Updated
November 18, 2011
Record last verified: 2011-11